Free shipping on all orders over $ 500

Agomelatine

Cat. No. M2230

All AbMole products are for research use only, cannot be used for human consumption.

Agomelatine Structure
Synonym:

Valdoxan; Melitor; S-20098

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 50  USD50 In stock
1mg USD 20  USD20 In stock
5mg USD 40  USD40 In stock
10mg USD 70  USD70 In stock
50mg USD 216  USD216 In stock
100mg USD 330  USD330 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. Agomelatine is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine abolishes 5-HT2C agonist effects both in cells and in vivo. 

Agomelatine also dose dependently increases extracellular levels of noradrenaline and dopamine in frontal cortex of freely moving rats. Agomelatine (25, 50, or 75 mg/kg; i.p.) has antioxidant activity in Strychnine (75 mg/kg, i.p.) or Pilocarpine (400 mg/kg, i.p.) induced seizure models in mice. Agomelatine dose not have any antioxidant effects on parameters of oxidative stress produced by Pentylenetetrazole (PTZ) or Picrotoxin (PTX) induced seizure models when compared to controls.

Chemical Information
Molecular Weight 243.3
Formula C15H17NO2
CAS Number 138112-76-2
Solubility (25°C) DMSO 60 mg/mL
Ethanol 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] George Konstantakopoulos, et al. The preclinical discovery and development of agomelatine for the treatment of depression

[2] Enrico Smeraldi, et al. Agomelatine in depression

[3] Carlos Clayton Torres Aguiar, et al. Cell Mol Neurobiol. Effects of agomelatine on oxidative stress in the brain of mice after chemically induced seizures

[4] Valerie Audinot, et al. Naunyn Schmiedebergs Arch Pharmacol. New selective ligands of human cloned melatonin MT1 and MT2 receptors

[5] M J Millan, et al. J Pharmacol Exp Ther . The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Related Melatonin Receptor Products
Melatonin

Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation.

Ramelteon (TAK-375)

Ramelteon (TAK-375) is a novel melatonin receptor agonist for human MT1 and MT2 receptors and chick forebrain melatonin receptors with Ki of 14 pM, 112 pM and 23.1 pM, respectively.

2-Phenylmelatonin

2-Phenylmelatonin is a potent melatonin agonist.

Luzindole

Luzindole (N-0774) is a selective competitive melatonin MT1/MT2 antagonist with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively.

Tasimelteon

Tasimelteon (BMS-214778) is a Dual Melatonin Receptor Agonist (DMRA) recently approved (Hetlioz) for the treatment of Non-24-hour sleep–wake disorder, a disorder primarily found in the totally blind, where a lack of normal synchronization between the 24-hour light–dark cycle and the endogenous circadian rhythm causes it to drift out of alignment with conventional sleep–wake schedules.

  Catalog
Abmole Inhibitor Catalog




Keywords: Agomelatine, Valdoxan; Melitor; S-20098 supplier, Melatonin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.